American Shared Hospital Q2 Results: Revenue up 19% to $8.4 million
American Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.
How this was made
The 30-second read
Why it matters
Q2 shows strong top-line momentum and segment-specific growth, but profitability weakened on an adjusted EBITDA basis, while liquidity improved via operating cash flow and higher cash balances. Post-quarter, the company amended its bank agreement and received subordinated financing to improve flexibility.
Market read
Traders can update near-term expectations for margin trajectory and financing risk after the company disclosed Q2 results plus post-quarter debt forbearance and subordinated funding.
What to watch
Non-operating items (credit losses and legal costs) and the expired Gamma Knife customer agreement may distort profitability comparisons, so traders should separate operating momentum from one-time charges.
Background
American Shared Hospital Services is transitioning from equipment leasing toward a diversified radiation oncology platform, emphasizing direct patient services and Proton Beam Radiation Therapy.
Ticker impact
American Shared Hospital Services reported Q2 2026 revenue up 19% to $8.4M, with direct patient services up ~40% YoY.
Near-term trading likely hinges on whether investors view the EBITDA decline as temporary transition costs versus a structural margin issue.
The article provides hard quarterly figures: revenue +19% and direct services +40%, while adjusted EBITDA declined to ~$1.3M from ~$1.7M despite sequential gross margin improvement.
Market effects
Highlights execution risk for radiation oncology operators shifting from equipment leasing to higher-touch direct services, where costs may lag revenue.
Mentions utilization focus in Rhode Island and recovery in Peru, suggesting uneven international demand execution.
Limited global read-through beyond oncology services, as the update is company-specific and regionally focused.
Counterpoint
The EBITDA decline could be largely transitional and already partially offset by improving gross margin sequentially, so the market may re-rate if utilization gains persist.
Key entities
- companyAmerican Shared Hospital Services
Reported Q2 2026 revenue growth, segment performance, adjusted EBITDA decline, liquidity changes, and post-quarter financing/forbearance actions.
- lenderFifth Third Bank
Entered into a Third Amendment and Forbearance Agreement with the company after quarter end.
- executiveRay Stokowiak
Executive Chairman purchased additional shares and provided $2M subordinated financing via a new company.
- partnerHospital San Xavier
Named as a Latin America partner in Guadalajara for upgrading a Gamma Knife center.
